摘要
Therapeutic Apheresis and DialysisEarly View LETTER TO THE EDITOR Two successful pregnancies in a woman with Fabry continuing enzyme replacement therapy Saime Paydas, Corresponding Author Saime Paydas [email protected] orcid.org/0000-0001-6651-8265 Departments of Internal Medicine Nephrology, Cukurova University Faculty of Medicine, Adana, Turkey Correspondence Saime Paydas, Departments of Internal Medicine Nephrology, Cukurova University Faculty of Medicine, Sarıcam/Adana 01330, Turkey. Email: [email protected]Search for more papers by this authorCigdem Akcabay, Cigdem Akcabay orcid.org/0000-0003-2068-7412 Departments of Obstetrics, Cukurova University Faculty of Medicine, Adana, TurkeySearch for more papers by this author Saime Paydas, Corresponding Author Saime Paydas [email protected] orcid.org/0000-0001-6651-8265 Departments of Internal Medicine Nephrology, Cukurova University Faculty of Medicine, Adana, Turkey Correspondence Saime Paydas, Departments of Internal Medicine Nephrology, Cukurova University Faculty of Medicine, Sarıcam/Adana 01330, Turkey. Email: [email protected]Search for more papers by this authorCigdem Akcabay, Cigdem Akcabay orcid.org/0000-0003-2068-7412 Departments of Obstetrics, Cukurova University Faculty of Medicine, Adana, TurkeySearch for more papers by this author First published: 08 November 2023 https://doi.org/10.1111/1744-9987.14081Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Brady R. Enzymatic abnormalities in diseases of sphingolipid metabolism. Clin Chem. 1967; 14: 565–577. 10.1093/clinchem/13.7.565 CASWeb of Science®Google Scholar 2Madsen CV, Christensen EI, Nielsen R, Mogensen H, Rasmussen ÅK, Feldt-Rasmussen U. Enzyme replacement therapy during pregnancy in Fabry patients: review of published cases of live births and a new case of a severely affected female with Fabry disease and pre-eclampsia complicating pregnancy. JIMD Rep. 2019; 44: 93–101. 10.1007/8904_2018_129 PubMedGoogle Scholar 3Whybra C, Wendrich K, Ries M, Gal A, Beck M. Clinical manifestation in female Fabry. Contrib Nephrol. 2001; 136: 245–250. 10.1159/000060196 PubMedWeb of Science®Google Scholar 4Fernández P, Fernández SO, Gonzalez JGM, Fernández T, Fernández CC, Fernández SP. Enzyme replacement therapy in pregnant women with Fabry disease: a case series. JIMD Rep. 2019; 45: 77–81. 10.1007/8904_2018_141 PubMedGoogle Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation